FI922963A0 - Hirudinanalog, foerfarande foer fram- staellning av den, antikoagulantkomposition och avsoendringsvektor, transformerade mikro-organismer som innehaoller naemnda vektor och foerfarande foer framstaellning av produkter vilka producerats av naemnda mikro-organism. - Google Patents

Hirudinanalog, foerfarande foer fram- staellning av den, antikoagulantkomposition och avsoendringsvektor, transformerade mikro-organismer som innehaoller naemnda vektor och foerfarande foer framstaellning av produkter vilka producerats av naemnda mikro-organism.

Info

Publication number
FI922963A0
FI922963A0 FI922963A FI922963A FI922963A0 FI 922963 A0 FI922963 A0 FI 922963A0 FI 922963 A FI922963 A FI 922963A FI 922963 A FI922963 A FI 922963A FI 922963 A0 FI922963 A0 FI 922963A0
Authority
FI
Finland
Prior art keywords
och
foerfarande foer
vector
transformerade
produko
Prior art date
Application number
FI922963A
Other languages
English (en)
Other versions
FI107928B (fi
FI922963A (fi
Inventor
Saturo Misawa
Hitoshi Matsuda
Yoshifumi Inoue
Hideyuki Furuya
Original Assignee
Nippon Mining Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from JP2303096A external-priority patent/JPH07119237B2/ja
Priority claimed from JP4127191A external-priority patent/JP3226289B2/ja
Application filed by Nippon Mining Co filed Critical Nippon Mining Co
Publication of FI922963A0 publication Critical patent/FI922963A0/fi
Publication of FI922963A publication Critical patent/FI922963A/fi
Application granted granted Critical
Publication of FI107928B publication Critical patent/FI107928B/fi

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/81—Protease inhibitors
    • C07K14/815—Protease inhibitors from leeches, e.g. hirudin, eglin
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/10—Processes for the isolation, preparation or purification of DNA or RNA
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14—Hydrolases (3)
    • C12N9/16—Hydrolases (3) acting on ester bonds (3.1)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C07K2319/01—Fusion polypeptide containing a localisation/targetting motif
    • C07K2319/02—Fusion polypeptide containing a localisation/targetting motif containing a signal sequence
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C07K2319/01—Fusion polypeptide containing a localisation/targetting motif
    • C07K2319/036—Fusion polypeptide containing a localisation/targetting motif targeting to the medium outside of the cell, e.g. type III secretion
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C07K2319/33—Fusion polypeptide fusions for targeting to specific cell types, e.g. tissue specific targeting, targeting of a bacterial subspecies

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Wood Science & Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Zoology (AREA)
  • Biomedical Technology (AREA)
  • General Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Biotechnology (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Microbiology (AREA)
  • Medicinal Chemistry (AREA)
  • Biophysics (AREA)
  • Crystallography & Structural Chemistry (AREA)
  • Plant Pathology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Physics & Mathematics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines Containing Plant Substances (AREA)
FI922963A 1990-11-08 1992-06-26 Erityskuljetin hirudiinin tai hirudiinianalogin tuottamiseksi, kyseessä olevan kuljettimen sisältävät muutetut mikro-organismit, sekä hirudiinin tai hirudiinianalogin valmistusmenetelmä FI107928B (fi)

Applications Claiming Priority (6)

Application Number Priority Date Filing Date Title
JP30309690 1990-11-08
JP2303096A JPH07119237B2 (ja) 1990-11-08 1990-11-08 ヒルジン変異体，その製造法及び抗凝血剤
JP4127191A JP3226289B2 (ja) 1991-02-13 1991-02-13 分泌ベクター、該ベクターで形質転換した微生物及び該微生物から産生される産物の製造法
JP4127191 1991-02-13
PCT/JP1991/001533 WO1992008736A1 (fr) 1990-11-08 1991-11-08 Mutant d'hirudine, sa production, anticoagulant, vecteur secretoire, microorganisme transforme par ledit vecteur et production d'un produit a partir dudit microorganisme
JP9101533 1991-11-08

Publications (3)

Publication Number Publication Date
FI922963A0 true FI922963A0 (fi) 1992-06-26
FI922963A FI922963A (fi) 1992-06-26
FI107928B FI107928B (fi) 2001-10-31

Family

ID=26380836

Family Applications (1)

Application Number Title Priority Date Filing Date
FI922963A FI107928B (fi) 1990-11-08 1992-06-26 Erityskuljetin hirudiinin tai hirudiinianalogin tuottamiseksi, kyseessä olevan kuljettimen sisältävät muutetut mikro-organismit, sekä hirudiinin tai hirudiinianalogin valmistusmenetelmä

Country Status (12)

Country Link
US (2) US5516656A (fi)
EP (2) EP0511393B1 (fi)
AT (2) ATE176500T1 (fi)
AU (2) AU648124B2 (fi)
CA (2) CA2255396A1 (fi)
DE (2) DE69121192T2 (fi)
DK (2) DK0687731T3 (fi)
ES (2) ES2129749T3 (fi)
FI (1) FI107928B (fi)
GR (2) GR3021410T3 (fi)
NO (2) NO303735B1 (fi)
WO (1) WO1992008736A1 (fi)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA1341417C (fr) * 1984-03-27 2003-01-21 Paul Tolstoshev Vecteurs d'expression de l'hirudine, cellules transformees et procede de preparation de l'hirudine
DE4009268A1 (de) * 1990-03-22 1991-09-26 Consortium Elektrochem Ind Sekretion von hirudinderivaten
US5972648A (en) * 1993-09-28 1999-10-26 Japan Energy Corporation Hirudin analogs, methods of manufacture thereof and anticoagulant compositions having these as active ingredients
WO1996016173A2 (en) * 1994-11-21 1996-05-30 The University Of Leeds Modified proteinase inhibitors
DE19944870A1 (de) 1999-09-18 2001-03-29 Aventis Pharma Gmbh Signalsequenzen zur Herstellung von Leu-Hirudin über Sekretion durch E. coli in das Kulturmedium
DE10108212A1 (de) * 2001-02-20 2002-08-22 Aventis Pharma Gmbh Fusionsprotein zur Sekretion von Wertprotein in bakterielle Überstände
US7202059B2 (en) 2001-02-20 2007-04-10 Sanofi-Aventis Deutschland Gmbh Fusion proteins capable of being secreted into a fermentation medium
DE10108211A1 (de) * 2001-02-20 2002-08-22 Aventis Pharma Gmbh Verwendung von Fusionsproteinen, deren N-terminaler Anteil aus einem Hirudinderivat besteht, zur Herstellung rekombinanter Proteine über Sekretion durch Hefen
US7638618B2 (en) 2001-02-20 2009-12-29 Sanofi-Aventis Deutschland Gmbh Nucleic acids encoding a hirudin and pro-insulin as superscretable peptides and for parallel improvement of the exported forms of one or more polypeptides of interest
KR100447530B1 (ko) * 2001-08-14 2004-09-08 한국과학기술원 ＯｍｐＦ를 이용하여 목적 단백질을 대장균 세포외로분비생산하는 방법
CA2496990A1 (en) 2002-08-23 2004-03-04 E.I. Du Pont De Nemours And Company Utilization of starch products for biological production by fermentation
JP2006096668A (ja) * 2002-11-08 2006-04-13 Ono Pharmaceut Co Ltd エラスターゼ阻害剤と血液凝固系および／または線溶系酵素阻害剤との組み合わせからなる医薬
US7795205B2 (en) * 2004-04-12 2010-09-14 Canyon Pharmaceuticals, Inc. Methods for effecting regression of tumor mass and size in a metastasized pancreatic tumor
DE602005023429D1 (de) 2004-10-19 2010-10-21 Lonza Ag Verfahren zur festphasen-peptidsynthese
DE502006009060D1 (de) * 2006-09-22 2011-04-21 Wacker Chemie Ag Verfahren zur fermentativen Herstellung von Antikörpern
CN101372512B (zh) * 2007-08-23 2011-03-23 中国人民解放军军事医学科学院生物工程研究所 一类抗凝血多肽及其用途
WO2010054503A1 (zh) * 2008-11-17 2010-05-20 中国人民解放军军事医学科学院生物工程研究所 抗凝血多肽及其应用
CN115572329B (zh) * 2021-06-21 2024-02-06 王大勇 一组活性增强代谢较慢的菲牛蛭基因重组水蛭素及其制备方法

Family Cites Families (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2562088B1 (fr) * 1984-03-27 1987-11-13 Transgene Sa Vecteurs d'expression de l'hirudine, cellules transformees et procede de preparation de l'hirudine
DE3586386T2 (de) * 1984-10-05 1993-01-14 Genentech Inc Dna, zellkulturen und verfahren zur sekretion von heterologen proteinen und periplasmische proteinrueckgewinnung.
DE3445532A1 (de) * 1984-12-13 1986-06-19 Plantorgan Werk Heinrich G.E. Christensen, KG, 2903 Bad Zwischenahn Hirudin-pa, desulfatohirudine-pa, verfahren zur herstellung und pharmazeutische mittel, die diese wirkstoffe enthalten
DE3506992A1 (de) * 1985-02-27 1986-08-28 Plantorgan Werk Heinrich G.E. Christensen, KG, 2903 Bad Zwischenahn Modifizierte hirudine, verfahren zu deren herstellung und pharmazeutische mittel, die diese wirkstoffe enthalten
FR2607517B2 (fr) * 1986-12-01 1989-12-22 Transgene Sa Vecteurs d'expression de variants de l'hirudine dans les levures, procede et produit obtenu
US5084384A (en) * 1987-04-23 1992-01-28 Monsanto Company Secretion of insulin-like growth factor-I
JP2518862B2 (ja) * 1987-08-31 1996-07-31 株式会社蛋白工学研究所 新規プラスミドベクタ―
AU604925B2 (en) * 1988-02-23 1991-01-03 Schering Aktiengesellschaft A hirudin derivative
AU614121B2 (en) 1988-05-04 1991-08-22 Novartis Ag Improvements in the production of polypeptides
ES2052062T3 (es) * 1988-06-11 1994-07-01 Ciba Geigy Ag Nuevos polipeptidos con actividad anticoagulante.
US5268296A (en) * 1988-06-11 1993-12-07 Ciba-Geigy Corporation DNA vector and recombinant host cell for production of hirullin P6 and P18
JPH0227993A (ja) * 1988-07-15 1990-01-30 Nippon Shinyaku Co Ltd ｈＥＧＦの製法
JPH0648988B2 (ja) 1988-07-26 1994-06-29 工業技術院長 トロンビン阻害物質の製造法
US5223407A (en) * 1988-08-31 1993-06-29 Allelix Inc. Excretion of heterologous proteins from e. coli
JPH0292288A (ja) * 1988-09-30 1990-04-03 Japan Tobacco Inc アクアライシンｉ前駆体をコードする遺伝子、それを含む発現ベクター、該発現ベクターを含む大腸菌及びそれを用いたアクアライシンｉの製造方法
DE3835815A1 (de) * 1988-10-21 1990-04-26 Hoechst Ag Neue isohirudine
JPH03164184A (ja) 1989-08-10 1991-07-16 Nippon Mining Co Ltd ヒルジン発現ベクター、ヒルジン融合蛋白、形質転換微生物及びヒルジンの製造法
PT94949A (pt) * 1989-08-10 1991-05-22 Nippon Mining Co Vector de expressao para hirudina, microorganismos transformados e metodos para a producao de hirudina
JPH0376579A (ja) 1989-08-18 1991-04-02 Nippon Mining Co Ltd ヒト‐アンジオジェニン発現ベクター及びヒト‐アンジオジェニンの製造方法
GB9010552D0 (en) * 1990-05-10 1990-07-04 Erba Carlo Spa Method for the recombinant production of hirudins and novel hirudins

Also Published As

Publication number Publication date
CA2072375C (en) 2000-01-11
ATE140929T1 (de) 1996-08-15
EP0511393A4 (en) 1993-08-11
FI107928B (fi) 2001-10-31
AU648124B2 (en) 1994-04-14
NO922671D0 (no) 1992-07-07
ES2093717T3 (es) 1997-01-01
ATE176500T1 (de) 1999-02-15
US5516656A (en) 1996-05-14
US5573929A (en) 1996-11-12
EP0511393B1 (en) 1996-07-31
DE69121192D1 (de) 1996-09-05
GR3029824T3 (en) 1999-06-30
AU8846691A (en) 1992-06-11
NO982207L (no) 1992-09-07
CA2255396A1 (en) 1992-05-09
EP0687731A1 (en) 1995-12-20
AU5470194A (en) 1994-03-24
EP0511393A1 (en) 1992-11-04
GR3021410T3 (en) 1997-01-31
EP0687731B1 (en) 1999-02-03
DE69130872D1 (de) 1999-03-18
DE69121192T2 (de) 1997-02-20
CA2072375A1 (en) 1992-05-09
ES2129749T3 (es) 1999-06-16
NO922671L (no) 1992-09-07
DK0511393T3 (da) 1996-12-09
FI922963A (fi) 1992-06-26
DK0687731T3 (da) 1999-09-20
NO982207D0 (no) 1998-05-14
WO1992008736A1 (fr) 1992-05-29
DE69130872T2 (de) 1999-08-26
AU673870B2 (en) 1996-11-28
NO303735B1 (no) 1998-08-24

Similar Documents

Publication Publication Date Title
FI922963A0 (fi) Hirudinanalog, foerfarande foer fram- staellning av den, antikoagulantkomposition och avsoendringsvektor, transformerade mikro-organismer som innehaoller naemnda vektor och foerfarande foer framstaellning av produkter vilka producerats av naemnda mikro-organism.
DE3856265D1 (de) Varianten des pankreatischen Rinder-Trypsininhibitors, deren Herstellung und Verwendung
NO953033L (no) Stabile baktericid/permeabilitetsökende proteinprodukter og farmasöytiske preparater inneholdende disse
DE3683267D1 (de) Gm-csf-protein, seine derivate, herstellung solcher proteine und ihre verwendung.
ES2017122A6 (es) Procedimiento de preparacion de proteina de ligado de heparina.
CA2088068A1 (en) Protein structure of the plant toxin gelonin
ATE211765T1 (de) Neue familie von proteaseinhibitoren und andere biologisch aktive substanzen
ATE216706T1 (de) Peptide des hiv-gag proteins, ihre herstellung und verwendung
EP0352707A3 (en) An expression system for the secretion of bioactive human granulocyte macrophage colony stimulating factor (gm-csf) and other heterologous proteins from streptomyces
WO1990003394A3 (fr) Nouvelles lymphokines, sequences d'adn codant pour ces lymphokines et compositions pharmaceutiques contenant ces lymphokines
AU5110390A (en) Cdna coding for placental protein 9 (pp9), the isolation and use thereof

Legal Events

Date Code Title Description
HC Name/ company changed in application

Owner name: JAPAN ENERGY CORPORATION